相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Differential gene expression indicates that 'buffalo hump' is a distinct adipose tissue disturbance in HIV-1-associated lipodystrophy
Jordi P. Guallar et al.
AIDS (2008)
HIV-protease inhibitors induce expression of suppressor of cytokine signaling-1 in insulin-sensitive tissues and promote insulin resistance and type 2 diabetes mellitus
Michael J. Carper et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
Regulation of macrophage functions by PPAR-α, PPAR-γ, and LXRs in mice and men
Elena Rigamonti et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity
Leonie K. Heilbronn et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
The human lipodystrophy gene BSCL2/Seipin may be essential for normal adipocyte differentiation
Victoria A. Payne et al.
DIABETES (2008)
Molecular determinants of brown adipocyte formation and function
Stephen R. Farmer
GENES & DEVELOPMENT (2008)
Drug-specific effect of nelfinavir and stavudine on primary culture of human preadipocytes
Corinne Saillan-Barreau et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2008)
PGC-1α integrates insulin signaling, mitochondrial regulation, and bioenergetic function in skeletal muscle
Ines Pagel-Langenickel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Lipodystrophy in HIV 1-infected patients: lessons for obesity research
F. Villarroya et al.
INTERNATIONAL JOURNAL OF OBESITY (2007)
A mouse model of conditional lipodystrophy
Suyeon Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Human lipodystrophies linked to mutations in A-type lamins and to HIV protease inhibitor therapy are both associated with prelamin A accumulation, oxidative stress and premature cellular senescence
M. Caron et al.
CELL DEATH AND DIFFERENTIATION (2007)
HIV protease inhibitors block the zinc metalloproteinase ZMPSTE24 and lead to an accumulation of prelamin A in cells
Catherine Coffinier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Unexpected evidence for active brown adipose tissue in adult humans
Jan Nedergaard et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
PPARγ in human and mouse physiology
Sami Heikkinen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2007)
High-dose Lopinavir/Ritonavir in highly treatment-experienced HIV-1 patients: Efficacy, safety, and predictors of response
Daniel Podzamczer et al.
HIV CLINICAL TRIALS (2007)
Macrophage-specific PPARγ controls alternative activation and improves insulin resistance
Justin I. Odegaard et al.
NATURE (2007)
PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism
Gema Medina-Gomez et al.
PLOS GENETICS (2007)
Hypotension, lipodystrophy, and insulin resistance in generalized PPARγ-deficient mice rescued from embryonic lethality
Sheng Zhong Duan et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Less lipoatrophy and better lipid profile with abacavir as compared to stavudine -: 96-week results of a randomized study
Daniel Podzamczer et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2007)
PPARs and Adipose Cell Plasticity
Louis Casteilla et al.
PPAR RESEARCH (2007)
Inhibition of human preadipocyte proteasomal activity by HIV protease inhibitors or specific inhibitor lactacystin leads to a defect in adipogenesis, which involves matrix metalloproteinase-9
Sandra De Barros et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Long-term treatment with lopinavir-ritonavir induces a reduction in peripheral adipose depots in mice
Matthieu Prot et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Effects of atazanavir/ritonavir and lopinavir/ritonavir on glucose uptake and insulin sensitivity:: demonstrable differences in vitro and clinically
Mustafa A. Noor et al.
AIDS (2006)
Microarray analysis during adipogenesis identifies new genes altered by antiretroviral drugs
Monia Pacenti et al.
AIDS (2006)
Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications
Rhian M. Touyz et al.
VASCULAR PHARMACOLOGY (2006)
Metabolic consequences of lipodystrophy in mouse models
Karen Reue et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2006)
Mixed patterns of changes in central and peripheral fat following initiation of antiretroviral therapy in a randomized trial
K Mulligan et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2006)
PPARγ and human metabolic disease
RK Semple et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Nuclear lamin A inhibits adipocyte differentiation: implications for Dunnigan-type familial partial lipodystrophy
RL Boguslavsky et al.
HUMAN MOLECULAR GENETICS (2006)
Understanding and avoiding antiretroviral adverse events
S Shibuyama et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
Ritonavir impairs lipoprotein lipase-mediated lipolysis and decreases uptake of fatty acids in adipose tissue
MAM den Boer et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Pronounced lipoatrophy in HIV-infected men receiving HAART for more than 6 years compared with the background population
AB Hansen et al.
HIV MEDICINE (2006)
Toxic metabolic syndrome associated with HAART
Steen B. Haugaard
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2006)
Molecular activation of PPAR gamma by angiotensin II type 1-receptor antagonists
David V. Erbe et al.
VASCULAR PHARMACOLOGY (2006)
HIV protease inhibitor-specific alterations in human adipocyte differentiation and metabolism
Roy J. Kim et al.
OBESITY (2006)
Assessment of adipokine expression and mitochondrial toxicity in HIV patients with lipoatrophy on stavudineand zidovudine-containing regimens
SP Jones et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2005)
Tumour necrosis factor alpha in fat redistribution syndromes associated with combination antiretroviral therapy in HIV-1-infected patients: potential role in subcutaneous adipocyte apoptosis
P Domingo et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2005)
Glucose metabolism, lipid, and body fat changes in antiretroviral-naive subjects randomized to nelfinavir or efavirenz plus dual nucleosides
MP Dubé et al.
AIDS (2005)
HIV protease inhibitors block adipocyte differentiation independently of lamin A/C
BA Kudlow et al.
AIDS (2005)
The effect of the HIV protease inhibitor ritonavir on proliferation, differentiation, lipogenesis, gene expression and apoptosis of human preadipocytes and adipocytes
S Grigem et al.
HORMONE AND METABOLIC RESEARCH (2005)
Altered pre-lamin A processing is a common mechanism leading to lipodystrophy
C Capanni et al.
HUMAN MOLECULAR GENETICS (2005)
In vivo, nucleoside reverse-transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes in the absence of depletion of mitochondrial DNA
PWG Mallon et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Alterations in thigh subcutaneous adipose tissue gene expression in protease inhibitor-based highly active antiretroviral therapy
J Chaparro et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2005)
Tissue-specific regulation of metabolic pathways through the transcriptional coactivator PGC1-α
P Puigserver
INTERNATIONAL JOURNAL OF OBESITY (2005)
Regulation of PPARγ activity during adipogenesis
SR Farmer
INTERNATIONAL JOURNAL OF OBESITY (2005)
C/EBPα reverses the anti-adipogenic effects of the HIV protease inhibitor nelfinavir
P Dowell et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
PPARγ-mediated insulin sensitization:: the importance of fat versus muscle
U Kintscher et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
Human immunodeficiency virus protease inhibitors accumulate into cultured human adipocytes and alter expression of adipocytokines
C Vernochet et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Medical progress - Cardiovascular risk and body-fat abnormalities in HIV-infected adults.
S Grinspoon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Cellular mechanisms of insulin resistance, lipodystrophy and atherosclerosis induced by HIV protease inhibitors
A Rudich et al.
ACTA PHYSIOLOGICA SCANDINAVICA (2005)
HIV antiretroviral treatment alters adipokine expression and insulin sensitivity of adipose tissue in vitro and in vivo
C Lagathu et al.
BIOCHIMIE (2005)
In vitro suppression of the lipogenic pathway by the nonnucleoside reverse transcriptase inhibitor efavirenz in 3T3 and human preadipocytes or adipocytes
K El Hadri et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Plasticity of human adipose lineage cells toward endothelial cells -: Physiological and therapeutic perspectives
V Planat-Benard et al.
CIRCULATION (2004)
Genetic variation in PPARG encoding peroxisome proliferator-activated receptor γ associated with carotid atherosclerosis
KZ Al-Shali et al.
STROKE (2004)
The HIV-1 nucleoside reverse transcriptase inhibitors stavudine and zidovudine alter adipocyte functions in vitro
M Caron et al.
AIDS (2004)
The effects of HIV protease inhibitors atazanavir and lopinavir/ritonavir on insulin sensitivity in HIV-seronegative healthy adults
MA Noor et al.
AIDS (2004)
Effects of rosiglitazone on gene expression in subcutaneous adipose tissue in highly active antiretroviral therapy-associated lipodystrophy
J Sutinen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2004)
Nelfinavir-induced insulin resistance is associated with impaired plasma membrane recruitment of the PI 3-kinase effectors Akt/PKB and PKC-ζ
R Ben-Romano et al.
DIABETOLOGIA (2004)
HIV protease inhibitor ritonavir induces lipoatrophy in male mice
ES Goetzman et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2003)
Some HIV protease inhibitors alter lamin A/C maturation and stability, SREBP-1 nuclear localization and adipocyte differentiation
M Caron et al.
AIDS (2003)
Differential effect of HIV protease inhibitors on adipogenesis: intracellular ritonavir is not sufficient to inhibit differentiation
C Vernochet et al.
AIDS (2003)
Mitochondrial toxicity of NRTI antiviral drugs: An integrated cellular perspective
W Lewis et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Expression of adipogenic transcription factors, peroxisome proliferator-activated receptor gamma co-activator 1, IL-6 and CD45 in subcutaneous adipose tissue in lipodystrophy associated with highly active antiretroviral therapy
K Kannisto et al.
AIDS (2003)
Serum adipocytokines are related to lipodystrophy and metabolic disorders in HIV-infected men under antiretroviral therapy
C Vigouroux et al.
AIDS (2003)
Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy
D Nolan et al.
AIDS (2003)
HIV protease inhibitors promote atherosclerotic lesion formation independent of dyslipidemia by increasing CD36-dependent cholesteryl ester accumulation in macrophages
J Dressman et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Agent and cell-type specificity in the induction of insulin resistance by HIV protease inhibitors
R Ben-Romano et al.
AIDS (2003)
A novel interaction between lamin A and SREBP1: implications for partial lipodystrophy and other laminopathies
DJ Lloyd et al.
HUMAN MOLECULAR GENETICS (2002)
Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance
JP Bastard et al.
LANCET (2002)
Effects of antiretroviral drug combinations on the differentiation of adipocytes
R Roche et al.
AIDS (2002)
Synergistic antiadipogenic effects of HIV type 1 protease inhibitors with tumor necrosis factor α:: Suppression of extracellular insulin action mediated by extracellular matrix-degrading proteases
D Mondal et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2001)
HIV protease inhibitor induces fatty acid and sterol biosynthesis in liver and adipose tissues due to the accumulation of activated sterol regulatory element-binding proteins in the nucleus
TM Riddle et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The HIV protease inhibitor indinavir impairs sterol regulatory element-binding protein-1 intranuclear localization, inhibits preadipocyte differentiation, and induces insulin resistance
M Caron et al.
DIABETES (2001)
Suppression of preadipocyte differentiation and promotion of adipocyte death by HIV protease inhibitors
P Dowell et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Lessons from lipodystrophy:: LMNA, encoding lamin A/C, in HIV therapy-associated lipodystrophy
GMN Behrens et al.
AIDS (2000)
The mechanism of insulin resistance caused by HIV protease inhibitor therapy
H Murata et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
